Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 7, 2013, Pages 1477-1481

  Giovanella, Luca ^a,b   Verburg, Frederik A ^c   Imperiali, Mauro ^b   Valabrega, Stefano ^d   Trimboli, Pierpaolo ^e   Ceriani, Luca ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b Ente Ospedaliero Cantonale ^*  (Switzerland)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Piazza San Bartolomeo All'Isola 21   (Italy)

Author keywords

calcitonin; medullary thyroid carcinoma; procalcitonin; thyroid nodule

Indexed keywords

CALCITONIN; PENTAGASTRIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER DIAGNOSIS; CYTOLOGY; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROVOCATION TEST; THYROID MEDULLARY CARCINOMA; THYROID NODULE;

ADULT; AGED; BIOPSY, FINE-NEEDLE; CALCITONIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PENTAGASTRIN; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL;

EID: 84883002121     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0610     Document Type: Article

References (26)

1. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351:1764-71.
2. Giuffrida D, Gharib H. Current diagnosis and management of medullary thyroid carcinoma. Ann Oncol 1998;9:695-701. (Pubitemid 28394153)
3. Lebolleux S, Baudin E, Travagli JP, Schlumberger M. Medullary thyroid carcinoma. Clin Endocrinol 2004;61:299-310. (Pubitemid 39287058)
4. Elisei R. Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008;22:941-53.
5. Karges D, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, et al.; German Society for Endocrinology (DGE)-Thyroid section. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goitre: German evidencebased consensus recommendation. Exp Clin Endocrinol Diab 2005;112:52-8. (Pubitemid 38220433)
6. daHerbomez M, Caron P, Bauters C, Do Cao C, Schlienger JL, Sapin R, et al.; French Group GTE (Groupe des Tumeurs Endocrines). Reference range of serum calcitonin levels in humans: Influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 2007;157:749-55.
7. Cavalier E, Carlisi A, Chapelle JP, Delanaye P. Analytical quality of calcitonin determination and its effect on the adequacy of screening for medullary carcinoma of the thyroid. Clin Chem 2008;54:29-30.
8. Barbot N, Calmettes C, Schuffenecker I, Saint-André JP, Franc B, Rohmer V, et al. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: Comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 1994;78:114-20.
9. Herrmann BL, Schmid KW, Goerges R, Kemen M, Mann K. Calcitonin screening and pentagastrin testing: Predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Eur J Endocrinol 2010;162:1141-5.
10. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803. (Pubitemid 43997716)
11. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, et al. Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid 2009;19:565-616.
12. Daniels GH. Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada. Thyroid 2011;21:1199-207.
13. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. AACE/AME Task Force on Thyroid Nodules. Endocr Pract 2010;6:S1-43.
14. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations. Crit Care Med 2008;36:941-52.
15. Algeciras-Schimnich A, Preissner CM, Theobald P, Finseth MS, Grebe SK. Procalcitonin: A marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 2009;94:861-8.
16. Kratzsch J, Petzold A, Raue F, Reinhardt W, Bröcker-Preuss M, Görges R, et al. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem 2011;57:467-74.
17. Giovanella L, Suriano S. Spurious hypercalcitoninemia and heterophilic antibodies in patients with thyroid nodules. Head Neck 2010;33:95-7.
18. Fadda G, Basolo F, Bondi A, Bussolati G, Crescenzi A, Nappi O, et al.; SIAPEC-IAP Italian Consensus Working Group. Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group. Pathologica 2010;102:405-8.
19. Matias-Guiu X, DeLellis R. Medullary thyroid carcinoma. Pathology and genetics of tumours of endocrine organs. In: DeLellis R, Lloyd R, Heitz P, Eng C, editors. World Health Organization classification of tumours. Lyon: IARC Press, 2004:86-91.
20. Costante G, Durante C, Francis Z, Schlumberger M, Filetti S. Determination of calcitonin in C-cell disease: Clinical interest and potential pitfalls. Nat Clin Pract Endocrinol Metabol 2009;5:35-44.
21. Giovanella L, Crippa S, Ceriani L. Serum calcitonin-negative medullary thyroid carcinoma: Role of CgA and CEA as complementary markers. Int J Biol Markers 2008;23:129-31.
22. Bugalho MJ, Santos JR, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 2005;91:56-60. (Pubitemid 40967381)
23. Valle LA, Kloos RT. The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab 2011;96:109-13.
24. Kim SH, Kin BS, Jung SL, Lee JW, Yang PS, Kang BJ, et al. Ultrasonographics findings of medullary thyroid carcinoma: A comparison with papillary thyroid carcinoma. Korean J Radiol 2009;10:101-5.
25. Lee S, Shin JH, Han BK, Ko EY. Medullary thyroid carcinoma: Comparison with papillary thyroid carcinoma and application of current sonographic criteria. Am J Roengtenol 2010;194:1090-4.
26. Trimboli P, Nasrollah N, Amendola S, Rossi F, Ramacciato G, Romanelli F, et al. Should we use ultrasound features associated with papillary thyroid cancer in diagnosing medullary thyroid cancer? Endocr J 2012;59:503-8.